endometriosis

Reading File
Finding Sources
Searching PubMed

endometriosis

Reading File
Reading File
Reading File
Reading File
Loading Image
Loading Image
Reading File
Loading Image
I now have comprehensive material to write a complete, well-illustrated answer. Here it is:

Endometriosis

Definition

Endometriosis is defined by the presence of endometrial glands and stroma in extrauterine locations. It is a common, chronic inflammatory condition affecting an estimated 5-10% of women of reproductive age, and nearly half of women with infertility.
  • Robbins & Kumar Basic Pathology, p. 689
  • Bailey and Love's Short Practice of Surgery, 28th Ed., p. 1602

Types

TypeDescription
Superficial peritonealMost common; implants on peritoneal surfaces
Ovarian endometriosisEndometriomas ("chocolate cysts") filled with brown, tar-like fluid
Deep infiltrating endometriosis (DIE)Tissue extending >5 mm below the peritoneum; involves uterosacral ligaments, vagina, bowel, bladder, ureters
Risk of malignant transformation is mainly confined to deep infiltrating endometriosis.

Pathogenesis

The mechanism remains incompletely understood. Four major theories exist:
  1. Regurgitation theory (Sampson's theory) - most widely accepted: menstrual tissue flows retrograde through the fallopian tubes and implants at ectopic sites.
  2. Benign metastasis theory: endometrial tissue spreads via blood vessels and lymphatics to distant sites (lung, brain, bone).
  3. Metaplastic theory: coelomic epithelium (from which the Mullerian ducts originate) undergoes metaplastic transformation into endometrial-like tissue.
  4. Extrauterine stem/progenitor cell theory: bone marrow-derived stem cells differentiate into endometrial tissue.
Once implanted, lesions are not passively inert. They produce elevated levels of aromatase (generating local estrogen from androgens), prostaglandin E2 (PGE2), VEGF, and matrix metalloproteinases (MMPs) - creating a self-sustaining, estrogen-driven, proinflammatory environment that promotes survival and growth of implants.
Pathogenesis of endometriosis - retrograde menstruation and the inflammatory/estrogenic mechanisms that sustain implants
Pathogenesis of endometriosis: retrograde menstruation deposits endometrial fragments at ectopic sites. Implants express aromatase, PGE2, and angiogenic factors (amplified by activated macrophages via COX-2), creating a positive feedback loop that promotes estrogen production and implant survival. (Robbins & Kumar Basic Pathology)

Sites of Involvement

Pelvic (most common):
  • Ovaries, pouch of Douglas, uterosacral ligaments, fallopian tubes, pelvic peritoneum
Extrapelvic (less common):
  • Gastrointestinal tract (sigmoid colon, rectum, small bowel - 12-37% of cases)
  • Urinary tract (bladder, ureters)
  • Lungs/diaphragm (can cause catamenial haemoptysis or pneumothorax)
  • Umbilicus, laparotomy scars

Gross and Microscopic Appearance

Classic ("powder burn") lesions: black, dark brown, or bluish puckered nodules or small cysts on serosal surfaces - reflecting old haemorrhage surrounded by fibrosis.
Atypical/subtle lesions: red flame-like implants, vesicular lesions, clear serous vesicles, white plaques - these are easily missed.
Endometriomas: ovarian cysts 3-5 cm in diameter, filled with thick dark brown ("chocolate") fluid; densely adherent to the ovarian fossa. Reported in 17-44% of women with endometriosis.
Deep disease: fibrotic nodules and adhesion bands that can obliterate the pouch of Douglas, distort pelvic anatomy, and involve the bowel wall (mimicking cancer).
Laparoscopic views - endometriosis on the peritoneal surface of the diaphragm:
Endometriosis on peritoneal surface of the diaphragm, laparoscopic view
Uterosacral ligament involvement with dense fibrosis:
Endometriosis on the uterosacral ligament

Symptoms

Endometriosis may be asymptomatic in a significant proportion of women. When symptomatic:
  • Dysmenorrhoea (most common)
  • Chronic pelvic pain (cyclical and non-cyclical)
  • Deep dyspareunia (pain during intercourse)
  • Dyschezia (pain on defaecation) - suggests bowel involvement
  • Dysuria / haematuria - suggests bladder involvement
  • Infertility
  • Fatigue
  • Catamenial haemoptysis or pneumothorax - with thoracic involvement
Note: there is poor correlation between disease extent/staging and symptom severity.

Diagnosis

Gold standard: laparoscopy with histological confirmation.
  • Clinical examination may reveal pelvic tenderness, a fixed retroverted uterus, tender uterosacral ligaments, or enlarged ovaries. Deeply infiltrating nodules in the pouch of Douglas or visible vaginal lesions ("blue-domed" cysts in the posterior fornix) are strongly suggestive.
  • Transvaginal ultrasound (TVUS): reliably detects endometriomas and severe pelvic DIE; misses superficial implants.
  • MRI: best non-invasive modality for mapping DIE; detects haemosiderin deposits and low-signal fibrotic plaques; can demonstrate obliteration of the pouch of Douglas and rectosigmoid involvement.
  • Sigmoidoscopy: useful when bowel involvement is suspected to assess depth and distance from anal verge (important for surgical planning).
MRI showing deep endometriotic rectovaginal nodule with obliteration of the pouch of Douglas:
Sagittal T2 MRI showing deep endometriotic nodule with rectovaginal involvement and obliteration of pouch of Douglas
Sagittal T2-weighted pelvic MRI: low-signal nodularity obliterating the pouch of Douglas (arrow), with tethering and angulation of the rectal wall to a deep rectovaginal endometriotic nodule (arrowhead). (Grainger & Allison's Diagnostic Radiology)

Treatment

Treatment options are influenced by the patient's desire for fertility, symptom severity, and disease extent.

1. Conservative (watchful waiting)

  • Appropriate for asymptomatic or mildly symptomatic women.

2. Medical Management

AgentMechanism
NSAIDs / simple analgesiaFirst-line for pain relief
Combined oral contraceptive pillSuppresses ovarian cycling
Progestogens (e.g., norethisterone, medroxyprogesterone)Decidualise and atrophy implants
Levonorgestrel IUS (Mirena)Local progestogenic effect; reduces dysmenorrhoea
GnRH agonists (e.g., leuprorelin, goserelin)Induce medical pseudomenopause; used with add-back HRT to reduce bone loss
Aromatase inhibitorsSuppress local and systemic estrogen; used in refractory cases
Hormonal therapies suppress but do not eradicate disease, and symptoms often recur after stopping.

3. Surgical Management

  • Laparoscopic ablation or excision of implants - preferred approach; restores anatomy.
  • For endometriomas: drainage with directed ablation preferred over cystectomy to preserve ovarian reserve.
  • For bowel DIE: shaving (superficial removal), disc excision, or segmental resection - depending on depth; low rectal lesions (5-8 cm from the anal verge) carry higher anastomotic leak risk.
  • Definitive surgery: total hysterectomy + bilateral salpingo-oophorectomy + excision of all disease - reserved for women who have completed their family. Offers best chance of cure but does not guarantee it.
Surgical risks include bowel/bladder/ureteric injury (2 in 1,000), ureteric stricture leading to hydronephrosis, fistula formation (with repeated bowel shavings), and anastomotic leak.

Endometriosis and Infertility

Endometriosis is found in approximately 40-50% of infertile women. Proposed mechanisms include:
  • Distortion of pelvic anatomy / adhesions impeding tubal pick-up
  • Impaired folliculogenesis and oocyte quality
  • Altered peritoneal fluid environment (inflammatory cytokines)
  • Endometrial receptivity defects
Surgical treatment of endometriomas and adhesions can improve spontaneous conception rates. In vitro fertilisation (IVF) is recommended for those who fail to conceive after conservative surgery.

Recent Evidence (2024-2025)

  • A 2024 systematic review (PMID 39067455) in Human Reproduction Update highlighted fibrosis as a key driver of endometriosis progression and pain, with emerging anti-fibrotic strategies under investigation.
  • A 2025 meta-analysis (PMID 39946383) in PLoS One found physical activity and exercise significantly reduced pain intensity and improved quality of life in women with endometriosis, supporting it as a complementary management strategy.

Sources:
  • Robbins & Kumar Basic Pathology, p. 689
  • Bailey and Love's Short Practice of Surgery, 28th Ed., p. 1602-1604
  • Grainger & Allison's Diagnostic Radiology, p. 591
  • PubMed: PMID 39067455, 39946383
This is a shared conversation. Sign in to Orris to start your own chat.